Company intelligence / Profile preview

Hathr AI

Springfield, Virginia, United Stateshathr.ai ↗

Ownership: Private
Development stage: Other

Overview

Hathr AI offers HIPAA-compliant generative artificial intelligence solutions for healthcare documentation review, clinical workflow automation, and secure data analysis. The platform enables real-time chart review and medical record summarization with significant productivity gains reported by users. It does not develop drugs or therapeutics but provides an enterprise-grade software solution for regulated industries. No clinical trial results are relevant as the product is not a therapeutic.

Modalities: SoftwareAI Tools
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Hathr AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hathr AI.

Explore the full profile